Swedish Orphan Biovitrum AB (publ) banner

Swedish Orphan Biovitrum AB (publ)
OTC:BIOVF

Watchlist Manager
Swedish Orphan Biovitrum AB (publ) Logo
Swedish Orphan Biovitrum AB (publ)
OTC:BIOVF
Watchlist
Price: 41.32 USD Market Closed
Market Cap: $14.2B

Wall Street
Price Targets

BIOVF Price Targets Summary
Swedish Orphan Biovitrum AB (publ)

Wall Street analysts forecast BIOVF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOVF is 48.81 USD with a low forecast of 34.1 USD and a high forecast of 57.54 USD.

Lowest
Price Target
34.1 USD
17% Downside
Average
Price Target
48.81 USD
18% Upside
Highest
Price Target
57.54 USD
39% Upside
Swedish Orphan Biovitrum AB (publ) Competitors:
Price Targets
PRDO
Perdoceo Education Corp
26% Upside
HCAT
Health Catalyst Inc
114% Upside
ESQ
Esquire Financial Holdings Inc
25% Upside

Revenue
Forecast

21% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
21% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 14 years the compound annual growth rate for Swedish Orphan Biovitrum AB (publ)'s revenue is 21%. The projected CAGR for the next 3 years is 12%.

Operating Income
Forecast

N/A
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

The compound annual growth rate of Swedish Orphan Biovitrum AB (publ)'s operating income for the next 3 years is 14%.

Net Income
Forecast

26% / Year
Past Growth
173% / Year
Estimated Growth
Estimates Accuracy
-22%
Average Miss
26% / Year
Past Growth
173% / Year
Estimated Growth
Estimates Accuracy
-22%
Average Miss

For the last 14 years the compound annual growth rate for Swedish Orphan Biovitrum AB (publ)'s net income is 26%. The projected CAGR for the next 3 years is 173%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOVF's stock price target?
Price Target
48.81 USD

According to Wall Street analysts, the average 1-year price target for BIOVF is 48.81 USD with a low forecast of 34.1 USD and a high forecast of 57.54 USD.

What is Swedish Orphan Biovitrum AB (publ)'s Revenue forecast?
Projected CAGR
12%

For the last 14 years the compound annual growth rate for Swedish Orphan Biovitrum AB (publ)'s revenue is 21%. The projected CAGR for the next 3 years is 12%.

What is Swedish Orphan Biovitrum AB (publ)'s Operating Income forecast?
Projected CAGR
14%

The compound annual growth rate of Swedish Orphan Biovitrum AB (publ)'s operating income for the next 3 years is 14%.

What is Swedish Orphan Biovitrum AB (publ)'s Net Income forecast?
Projected CAGR
173%

For the last 14 years the compound annual growth rate for Swedish Orphan Biovitrum AB (publ)'s net income is 26%. The projected CAGR for the next 3 years is 173%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett